Skip to content

Clinical Performance Study: Evaluate Scanning & Interpretation Performance With & Without ScanNav Anatomy PNB

A Pilot Study to Evaluate Anaesthetists' Ultrasound Scanning & Interpretation Performance for Ultrasound-guided Regional Anaesthesia - With & Without the Assistance of an Artificial Intelligence Device ScanNav Anatomy Peripheral Nerve Block

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05156099
Acronym
PNB
Enrollment
21
Registered
2021-12-14
Start date
2021-12-06
Completion date
2022-12-08
Last updated
2023-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ultrasound Imaging of Anatomical Structures

Brief summary

This is a single-centre, randomised, interventional prospective cohort study to be undertaken at offices of Intelligent Ultrasound Limited in Cardiff, United Kingdom.

Detailed description

Current National Institute for Health and Care Excellence (NICE) guidance (NICE, 2009) supports the use of ultrasound-guidance for regional anaesthesia (UGRA) procedures as a consensus of clinical opinion agrees that nerve blocks are more successful and safer with ultrasound (US) guidance. Despite this, UGRA remains a difficult technique to master. This study will be used to determine whether ScanNav Anatomy PNB can support the performance of non-expert anaesthetist in UGRA scanning by highlighting key anatomical structures on the US image in real time.

Interventions

The participants will be asked to perform clinically relevant tasks on multiple healthy volunteers while under observation by a subject matter expert (expert observer) who will assess participant performance.

DEVICEUltrasound Scanning - 2 months later

The participants will be asked to perform clinically relevant tasks on multiple healthy volunteers while under observation by a subject matter expert (expert observer) who will assess participant performance.

Sponsors

IntelligentUltrasound Limited
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Male or female, at least 18 years of age 2. Able to comprehend and sign the Informed Consent prior to enrolment in the study 3. Available to travel and attend the study day in person in Cardiff, UK 4. Medical professional (currently practicing anaesthetist or similar clinician) who is qualified to perform UGRA 5. Do not self-identify as an expert in the field of UGRA: 1. Has not completed advanced training or hold a qualification (e.g., EDRA, MSc, MD, PhD) related to UGRA 2. Does not regularly deliver anaesthesia for 'awake' surgery (excluding central neuraxial techniques) 3. Does not teach on formal RA courses

Exclusion criteria

1. Aged \<18 years of age 2. Unwilling or unable to provide informed consent 3. Expert in UGRA (see definition above)

Design outcomes

Primary

MeasureTime frameDescription
Correct identification of appropriate block site (at initial assessment and 2 months later)12 monthsQuantify the performance change associated with ScanNav Anatomy PNB during UGRA scanning: (for block regions of the upper limb, trunk, and lower limb). Correct identification of appropriate block site by participant \[expert observer's opinion; Y/N\]

Secondary

MeasureTime frameDescription
Time required to scan (at initial assessment and 2 months later)12 monthsQuantify the performance change associated with ScanNav Anatomy PNB during UGRA scanning: (for block regions of the upper limb, trunk, and lower limb) Time in seconds required for participant to scan \[to obtain a satisfactory view of an appropriate block site, in the participant's opinion\]
confidence in identifying an appropriate block site (at initial assessment and 2 months later)12 monthsQuantify the performance change associated with ScanNav Anatomy PNB during UGRA scanning: (for block regions of the upper limb, trunk, and lower limb) Participant confidence in identifying an appropriate block site \[0 (no confidence\] - 10 (total confidence)\]
Correct identification of key structures (at initial assessment and 2 months later)12 monthsQuantify the performance change associated with ScanNav Anatomy PNB during UGRA scanning: (for block regions of the upper limb, trunk, and lower limb) Correct identification of key structures (including safety critical) at that block site by participant \[expert observer's opinion; Y/N\]
Expert observer's assessment (at initial assessment and 2 months later)12 monthsQuantify the performance change associated with ScanNav Anatomy PNB during UGRA scanning (for block regions of the upper limb, trunk, and lower limb) Expert observer's assessment of the participant's total scanning performance \[0 (poor) - 10 (excellent)\]
Quantify the change in incorrect identification of safety critical anatomical structures (at initial assessment and 2 months later)12 monthsQuantify the change in incorrect identification of safety critical anatomical structures associated with ScanNav Anatomy PNB during UGRA scanning (for block regions of the upper limb, trunk and lower limb), False positive/negative identification rates for blood vessels, nerves, pleura and peritoneum by participant \[expert observer's opinion of participant judgement; Y/N\]

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026